Eric Lefkofsky´s Tempus Looks To Advance Precision Medicine

There is a copious number of recent advances in the area of precision medicine that is modified for patient subgroups rather than a universal drug for all. That is why Eric Lefkofsky founded Tempus in 2015 so that its innovative platform could leverage software artificial intelligence in numerous solutions. These include genomic profiling, data collaborations, […]